Table 3.
Results of leave-one-out cross-validation analyses
Case-Control
|
Factor Score
|
|||||
---|---|---|---|---|---|---|
Testing Sample | NSNPa Ptraining<10−5 |
NSNPb Ptesting<0.05 |
NSNP (same direction) | NSNPa Ptraining<10−5 |
NSNPb Ptesting<0.05 |
NSNP (same direction) |
MGS | 19 | 3 | 10 | 39 | 0 | 25 |
GSK | 26 | 3 | 12 | 22 | 4 | 11 |
RS1 | 24 | 0 | 13 | 42 | 6 | 36 |
RS2 | 15 | 3 | 9 | 45 | 0 | 33 |
RS3 | 22 | 0 | 10 | 46 | 21 | 35 |
SHIP | 24 | 0 | 14 | 40 | 10 | 32 |
NTR/NESDAc | 14 | 3 | 13 | - | - | - |
QIMR | 13 | 3 | 9 | 35 | 0 | 32 |
TRAILS | 16 | 3 | 13 | 46 | 2 | 41 |
OVERALL | 173 | 18* (P=0.001) | 103* (P=0.005) | 315 | 43* (P<0.001) | 245* (P<0.001) |
P<0.05 thresholds applied for replication and sign tests; Replication and sign tests are conducted based on permutations with 9,000 iterations in case-control and 8,000 iterations in factor score phenotype under the null hypothesis of no association (1,000 iteration for each pair of training and testing sets).
The number of SNPs associated at Ptraining<1×10−5 with r2<0.4 in the leave-one-out meta-analysis using N-1 training samples after removing one testing sample at a time.
Of the SNPs with Ptraining<1×10−5 in the meta-analysis of the N-1 training samples, the number of replicated SNPs with one-sided Ptesting<0.05 in the left-out (testing) sample.
Only case-control phenotype is available for NTR/NESDA sample.